AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Ruiz, L Negredo, E Domingo, P Paredes, R Francia, E Balague, M Gel, S Bonjoch, A Fumaz, CR Johnston, S Romeu, J Lange, J Clotet, B
Citation: L. Ruiz et al., Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy, J ACQ IMM D, 27(3), 2001, pp. 229-236

Authors: Negredo, E Domingo, P Sambeat, MA Rabella, N Vazquez, G
Citation: E. Negredo et al., Effect of pneumococcal vaccine on plasma HIV-1 RNA of stable patients undergoing effective highly active antiretroviral therapy, EUR J CL M, 20(4), 2001, pp. 287-288

Authors: Tuldra, A Fumaz, CR Ferrer, MJ Bayes, R Arno, A Balague, M Bonjoch, A Jou, A Negredo, E Paredes, R Ruiz, L Romeu, J Sirera, G Tural, C Burger, D Clotet, B
Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228

Authors: Lopez-Contreras, J Blanco-Vaca, F Borras, X Carreras, F Pons-Llado, G Gallego, F Sole, MJ Cirera, S Benet, MT Negredo, E Roca-Cusachs, A
Citation: J. Lopez-contreras et al., Usefulness of the I/D angiotensin-converting enzyme genotype for detectingthe risk of left ventricular hypertrophy in pharmacologically treated hypertensive men, J HUM HYPER, 14(5), 2000, pp. 327-331

Authors: Ruiz, L Martinez-Picado, J Romeu, J Paredes, R Zayat, MK Marfil, S Negredo, E Sirera, G Tural, C Clotet, B
Citation: L. Ruiz et al., Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS, 14(4), 2000, pp. 397-403

Authors: Torres, OH Negredo, E Ris, J Domingo, P Catafau, AM Contreras, JL
Citation: Oh. Torres et al., Tc-99m-HMPAO SPET: a method to study visual loss in cryptococcal meningitis, ACT NEUR SC, 102(5), 2000, pp. 340-341

Authors: Paredes, R Puig, T Arno, A Negredo, E Balague, M Bonjoch, A Jou, A Tuldra, A Tural, C Sirera, G Veny, A Romeu, J Ruiz, L Clotet, B
Citation: R. Paredes et al., High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response, J ACQ IMM D, 22(2), 1999, pp. 132-138

Authors: Negredo, E Paredes, R Bonjoch, A Tuldra, A Fumaz, CR Gel, S Garces, B Johnston, S Arno, A Balague, M Jou, A Tural, C Sirera, G Romeu, J Cruz, L Francia, E Domingo, P Arrizabalaga, J Ruiz, I Arribas, JR Ruiz, L Clotet, B
Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28

Authors: Torres, OH Negredo, E Ris, J Domingo, P Catafau, AM
Citation: Oh. Torres et al., Visual loss due to cryptococcal meningitis in AIDS patients, AIDS, 13(4), 1999, pp. 530-532

Authors: Fuster, M Negredo, E Cadafalch, J Domingo, P Illa, I Clave, P
Citation: M. Fuster et al., HIV-associated polymyositis with life-threatening myocardial and esophageal involvement, ARCH IN MED, 159(9), 1999, pp. 1012-1012

Authors: Negredo, E Domingo, P Sambeat, MA Rabella, N Vazquez, G
Citation: E. Negredo et al., Influence at coinfection with hepatitis viruses on human immunodeficiency plasma viral load, ARCH IN MED, 159(19), 1999, pp. 2367-2368

Authors: Ruiz, L Negredo, E Ruiz, L
Citation: L. Ruiz et al., Benefit of switching the Protease Inhibitor (PI) by nevirapine in PI - experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL). Interim analysis at 6 months of follw-up, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 49-54
Risultati: 1-12 |